John Eichorn


Sentinel Lymph Node Test Has No Effect on Overall Survival in Women With Early-Stage Breast Cancer

July 28th 2011

It had been thought that removing the sentinel node and the surrounding lymph nodes would improve survival rates.

Avastin Still Recommended by NCCN for Use Against Metastatic Breast Cancer

July 21st 2011

The NCCN voted to maintain the current recommendation and position on Avastin (bevacizumab) in its treatment of metastatic breast cancer.

Patients With Bladder Cancer Not Getting Recommended Care

July 14th 2011

Study results reveal that only a small fraction of patients with high-grade, noninvasive bladder cancer receive the appropriate treatment.

Colon Cancer Screening Saves Lives Yet Screening Rates Remain Below Standard

July 7th 2011

Almost 1 in 3 adults in the United States do not get screened regularly.

Screening With Low-Dose CT Scan Reduces Deaths From Lung Cancer

June 30th 2011

Patients screened with low-dose helical computed tomography (CT) reduced their risk of dying of lung cancer by 20% compared with chest x-ray.

Chemotherapy Drug Shortages Persist With No Real End in Sight

June 23rd 2011

Shortages of chemotherapy drugs continue to plague the healthcare industry.

Prolonged Use of Diabetes Drug Actos May Increase Risk of Bladder Cancer

June 16th 2011

The FDA announced that the prolonged use of pioglitazone (Actos) for more than 1 year has been linked to an increased risk of bladder cancer

Socioeconomic Status Bears Little Impact on Survival Rates

June 10th 2011

Primary cancers of the lung, esophagus, and pancreas-all of which have a poor prognosis-account for >35% of all cancer deaths in the United States annually

Experimental Melanoma Vaccine May Shrink Late-Stage Tumors

June 2nd 2011

An experimental melanoma vaccine gp100 peptide vaccine in combination with IL2 may shrink tumors and prevent the progression of late-stage melanoma

Fine-Tuning Cancer Care: NCCN Changes 11 Guidelines

June 1st 2011

Highlights on updates to the clinical practice guidelines from the annual National Comprehensive Cancer Network (NCCN) conference

Abiraterone Acetate Improves Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer

May 26th 2011

Men with advanced CRPC who were treated with abiraterone acetate plus prednisone/prednisolone had significant improvement in overall survival

A Conversation With Patricia Goldsmith

May 24th 2011

Interview with Patricia Goldsmith the executive vice president and chief operating officer of the National Comprehensive Cancer Network (NCCN)

NCCN's 16th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care

May 24th 2011

Each year the National Comprehensive Cancer Network (NCCN) presents the latest updates to its Clinical Practice Guidelines in Oncology, as well as the latest cancer therapies by key opinion leaders.

FDA Grants Priority Review to Pfizer's Crizotinib

May 19th 2011

Crizotinib was accepted for filing by the FDA and granted Priority Review status

Study Results Show Ovarian Cancer Deaths Are Not Reduced by Early-Detection Screening Methods

May 18th 2011

The risk of dying from ovarian cancer was not reduced when women received CA-125 blood testing and transvaginal ultrasound

Four-Drug Chemotherapy Combo Extends Lives of Patients with Pancreatic Cancer

May 12th 2011

Results from a phase III study showed that the chemotherapy combination FOLFIRINOX nearly doubled the survival time for patients with pancreatic adenocarcinoma

Senators Introduce Bill to Correct Medicare Reimbursement for Cancer Drugs

May 5th 2011

Reimbursement is often insufficient to cover the purchase cost of cancer drugs, forcing oncologists to pay out of pocket to treat patients

PARP Inhibitors May Help Fight Colon Cancer

April 28th 2011

A class of drugs that has shown encouraging results in breast and ovarian cancers with BRCA gene mutations may also benefit patients who have colorectal cancers

Study Finds that Air Pollution Can Lead to Breast Cancer

April 21st 2011

Exposure to air pollution at certain times in a woman's life can leave her more susceptible to premenopausal breast cancer

FDA Notes Increase in Rare Blood Cancers Associated with TNF Blockers

April 14th 2011

The FDA reported today that TNF blockers may be responsible for an increased incidence of HSTCL in adolescents and young adults